Home - Products - Cytoskeleton/Cell Adhesion Molecules - Akt - Protectin D1

Protectin D1

CAS No. 660430-03-5

Protectin D1( —— )

Catalog No. M34940 CAS No. 660430-03-5

Protectin D1 (Neuroprotectin D1) is a neuroprotectin produced by neuronal cells and is a potential cardioprotective agent.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
100MG	Get Quote	In Stock
200MG	Get Quote	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Protectin D1
Note

Research use only, not for human use.
Brief Description

Protectin D1 (Neuroprotectin D1) is a neuroprotectin produced by neuronal cells and is a potential cardioprotective agent.
Description

Protectin D1, neuroprotectin D1 when generated by neural cells, is a member of a new family of bioactive products generated from docosahexaenoic acid. Protectin D1 is also a specialized pro-resolving mediator with potent pro-resolving and anti-inflammatory effects in vivo in several human disease models.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Cytoskeleton/Cell Adhesion Molecules
Target

Akt
Recptor

Akt | PI3K
Research Area

——
Indication

——

Chemical Information

CAS Number

660430-03-5
Formula Weight

360.49
Molecular Formula

C22H32O4
Purity

>98% (HPLC)
Solubility

——
SMILES

[C@H](/C=C/C=C/C=C\[C@H](C/C=C\CC)O)(C/C=C\C/C=C\CCC(O)=O)O
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. Tungen JE, et al. Synthesis of protectin D1 analogs: novel pro-resolution and radiotracer agents. Org Biomol Chem. 2018;16(36):6818-6823.?

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

CYNARIN

CYNARIN is a natural product. It shows antioxidant and choleretic properties and is a potential immunosuppressive agent.
(E)-Akt inhibitor-IV

(E)-Akt inhibitor-IV? ((E)-AKTIV) is an inhibitor of PI3K-Akt.
Xentuzumab

Xentuzumab (BI836845) is a recombinant monoclonal antibody to humanised IGF ligand that inhibits IGF1 and IGF2 growth-promoting signalling and inhibits AKT activation for the study of solid tumours.

Sign In Join Free